Related Experiment Video
Updated: Apr 19, 2026

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
Published on: May 7, 2020
Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis
Background:
Approximately 7% of survivors from meningococcal meningitis (MM) suffer from neurological sequelae due to brain damage in the course of meningitis. The present study focuses on the role of matrix metalloproteinases (MMPs) in a novel mouse model of MM-induced brain damage.
Methods:
The model is based on intracisternal infection of BALB/c mice with a serogroup C Neisseria meningitidis strain. Mice were infected with meningococci and randomised for treatment with the MMP inhibitor batimastat (BB-94) or vehicle. Animal survival, brain injury and host-response biomarkers were assessed 48 h after meningococcal challenge.
Results:
Mice that received BB-94 presented significantly diminished MMP-9 levels (p < 0.01), intracerebral bleeding (p < 0.01), and blood-brain barrier (BBB) breakdown (p < 0.05) in comparison with untreated animals. In mice suffering from MM, the amount of MMP-9 measured by zymography significantly correlated with both intracerebral haemorrhage (p < 0.01) and BBB disruption (p < 0.05).
Conclusions:
MMPs significantly contribute to brain damage associated with experimental MM. Inhibition of MMPs reduces intracranial complications in mice suffering from MM, representing a potential adjuvant strategy in MM post-infection sequelae.
Insights
Matrix metalloproteinases (MMPs) contribute to brain damage from meningococcal meningitis (MM). Inhibiting MMPs with batimastat (BB-94) reduced brain injury and blood-brain barrier breakdown in a mouse model of MM.
Area of Science:
- Neuroscience
- Infectious Diseases
- Pharmacology
Background:
- Meningococcal meningitis (MM) survivors face neurological deficits due to brain damage.
- Matrix metalloproteinases (MMPs) are implicated in MM-induced brain injury.
Purpose of the Study:
- Investigate the role of MMPs in a novel mouse model of MM-induced brain damage.
- Evaluate the therapeutic potential of MMP inhibition.
Main Methods:
- Developed a mouse model of MM using intracisternal infection with Neisseria meningitidis.
- Administered the MMP inhibitor batimastat (BB-94) or vehicle to infected mice.
- Assessed survival, brain injury, and biomarkers 48 hours post-infection.
Main Results:
- Batimastat treatment significantly reduced MMP-9 levels, intracerebral bleeding, and blood-brain barrier (BBB) breakdown.
- MMP-9 levels strongly correlated with intracerebral hemorrhage and BBB disruption in MM mice.
Conclusions:
- MMPs play a significant role in brain damage during experimental MM.
- MMP inhibition offers a potential strategy to mitigate intracranial complications and sequelae of MM.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Role of Matrix Metalloproteases in Degradation of ECM

